Vodencarevic, Asmir
,
Tascilar, Koray
Hartmann, Fabian
Reiser, Michaela
Hueber, Axel J.
Haschka, Judith
Bayat, Sara
Meinderink, Timo
Knitza, Johannes
Mendez, Larissa
Hagen, Melanie
Krönke, Gerhard
Rech, Jürgen
Manger, Bernhard
Kleyer, Arnd
Zimmermann-Rittereiser, Marcus
Schett, Georg
Simon, David http://orcid.org/0000-0001-8310-7820
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2886 PANDORA, CRC1181 Checkpoints for Resolution of Inflammation)
Bundesministerium für Bildung und Forschung (MASCARA)
ERC Synergy grant (4D Nanoscope)
Innovative Medicines Initiative (RTCure)
Friedrich-Alexander-Universität Erlangen-Nürnberg (Emerging Fields Initiative MIRACLE)
Else Kröner-Fresenius-Stiftung (Memorial Scholarship (No. 2019_EKMS.27))
Article History
Received: 13 April 2020
Accepted: 10 February 2021
First Online: 27 February 2021
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Friedrich-Alexander University of Erlangen-Nuremberg, Germany (approval number Az:01_2010) and all local ethics committees of the external centers as well as the Paul-Ehrlich Institute; the study was conducted according to the ethical principles of the Declaration of Helsinki. Patients’ written informed consent was obtained.
: Not applicable
: None to declare.